Navigation Links
Lung cancer conference leaders honor Paul A. Bunn Jr., M.D.
Date:1/14/2010

CORONADO, Calif. The American Association for Cancer Research and the International Association for the Study of Lung Cancer (IASLC) honored Paul A. Bunn Jr., M.D., for his leadership in lung cancer research at the first Molecular Origins of Lung Cancer conference this week. The conference, held from Jan. 11-14, 2010, drew more than 300 people from around the world. Bunn is professor of medicine and the James Dudley chair in cancer research at the University of Colorado, Denver.

"Dr. Bunn has been an inspiration to physicians and scientists working in the field of lung cancer. He deserves this award for everything that he has contributed to this important field past, present and future," said conference co-chairperson Roy Herbst, M.D., Ph.D., chief of the section of thoracic medical oncology at The University of Texas M. D. Anderson Cancer Center.

Conference co-chairperson David Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research and director of the Specialized Program of Research Excellence in Lung Cancer at Vanderbilt-Ingram Cancer Center, concurred.

"Indeed, Bunn has done much to teach the next generation of scientists and clinicians about excellence in cancer research and treatment," said Carbone.

Bunn, a co-chairperson of the conference, said the combined efforts of the AACR and IASLC have helped to raise awareness of translational research.

"The AACR has been the leader in basic research for many years, and the IASLC has led the way in the clinical arena," said Bunn. "The joining of these two associations for this meeting is a strong indication of how important translational research has become for lung cancer and many other forms of cancer as well."

Lung cancer kills more people than breast, prostate, kidney, colon, liver and skin cancers combined. It is a critical area for future research, according to Bunn.

"Despite its prevalence and the terrible toll that lung cancer takes in terms of human life and suffering, this disease has not been well funded and has not been the focus of as much advocacy as some other cancers," Bunn said. "This is changing. This is a time when there is genuine new hope and optimism for improving the prognosis and quality of life for lung cancer patients."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert  

Related medicine news :

1. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
2. The first map of colon cancer in Spain is published
3. Stress on Cells Can Turn Them Cancerous
4. Capital BlueCross and P4 Healthcare Launch Cancer Pathways Initiative
5. Therapy May Relieve Breast Cancer Surgery Complication
6. Strides Made in Lung Cancer Treatment
7. Radon Gas Identified as Americas Leading In-Home Killer; EPA Takes Action to Prevent 20,000 U.S. Cancer Deaths Each Year
8. St. Helena Hospital Cancer Center Affiliates with the UCSF Medical Center to Enhance Local Cancer Care
9. The Foundation for Biomedical Research Releases New Breast Cancer PSA
10. Combo PET-CT Scans Can Spot Hidden Cancers
11. Alzheimers Drug Might Help Prevent Esophageal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung cancer conference leaders honor Paul A. Bunn Jr., M.D.
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: